KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515951. A total of 4 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,000 | +266.7% | 66 | +288.2% | 0.00% | – |
| Q2 2018 | $6,000 | +200.0% | 17 | -43.3% | 0.00% | – |
| Q1 2018 | $2,000 | -66.7% | 30 | -73.9% | 0.00% | – |
| Q4 2017 | $6,000 | +200.0% | 115 | +576.5% | 0.00% | – |
| Q3 2017 | $2,000 | -83.3% | 17 | -55.3% | 0.00% | -100.0% |
| Q2 2017 | $12,000 | -29.4% | 38 | -19.1% | 0.00% | 0.0% |
| Q1 2017 | $17,000 | -41.4% | 47 | -63.3% | 0.00% | -50.0% |
| Q4 2016 | $29,000 | -25.6% | 128 | +8.5% | 0.00% | -33.3% |
| Q3 2016 | $39,000 | +550.0% | 118 | +1375.0% | 0.00% | – |
| Q2 2016 | $6,000 | -40.0% | 8 | -86.4% | 0.00% | -100.0% |
| Q1 2016 | $10,000 | -23.1% | 59 | +28.3% | 0.00% | 0.0% |
| Q4 2015 | $13,000 | +18.2% | 46 | +283.3% | 0.00% | 0.0% |
| Q3 2015 | $11,000 | -54.2% | 12 | -91.7% | 0.00% | -50.0% |
| Q2 2015 | $24,000 | +140.0% | 145 | +237.2% | 0.00% | +100.0% |
| Q1 2015 | $10,000 | -37.5% | 43 | -52.7% | 0.00% | -50.0% |
| Q4 2014 | $16,000 | – | 91 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 211,700 | $745,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 158 | $56,000 | 0.00% |
| SIMPLEX TRADING, LLC | 12 | $11,000 | 0.00% |
| Citadel Advisors | 32,100 | $113,000 | 0.00% |